CLINICAL_TRIALS
trial_result
· 2020-07-22
Clinical Trial Update: Primary Progesterone Therapy for Operable Breast Cancer [Phase 2, Phase 3]
Summary
A Phase 2/Phase 3 clinical trial evaluating primary progesterone therapy for operable breast cancer has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Tata Memorial Hospital | Conditions: Breast Neoplasms | Phase 2, Phase 3 | Status: COMPLETED